Cervical Secretions from Women After Depot Medroxyprogesterone Acetate (Depo-Provera) Administration Promote HIV Infectivity Ex Vivo

Depot medroxyprogesterone acetate (Depo-Provera) has been associated with an increased risk of HIV acquisition. We have previously shown that Depo-Provera administration increases immune markers for HIV preference on peripheral and cervical CD4<sup>+</sup> T cells but decreases the level...

Full description

Bibliographic Details
Published in:Viruses
Main Authors: Carley Tasker, Natalie E. Roche, Yungtai Lo, Theresa L. Chang
Format: Article
Language:English
Published: MDPI AG 2025-09-01
Subjects:
Depo-Provera
vaginal and cervical mucosa
HIV infectivity
Online Access:https://www.mdpi.com/1999-4915/17/9/1283

Internet

https://www.mdpi.com/1999-4915/17/9/1283

Similar Items